{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:53:24Z","timestamp":1793051604107,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T00:00:00Z","timestamp":1749254400000},"content-version":"am","delay-in-days":371,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 HL125212"],"award-info":[{"award-number":["U01 HL125212"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 9 HL125215"],"award-info":[{"award-number":["U01 9 HL125215"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 HL125177"],"award-info":[{"award-number":["U01 HL125177"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 HL125208"],"award-info":[{"award-number":["U01 HL125208"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 HL125218"],"award-info":[{"award-number":["U01 HL125218"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 HL125205"],"award-info":[{"award-number":["U01 HL125205"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 HL125175"],"award-info":[{"award-number":["U01 HL125175"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K23 153778"],"award-info":[{"award-number":["K23 153778"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002291","name":"Pulmonary Hypertension Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002291","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CHEST"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.chest.2024.02.009","type":"journal-article","created":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T16:29:03Z","timestamp":1707755343000},"page":"1493-1504","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Health-Related Quality of Life Across the Spectrum of Pulmonary Hypertension"],"prefix":"10.1016","volume":"165","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1854-6672","authenticated-orcid":false,"given":"Aparna","family":"Balasubramanian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Brett","family":"Larive","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5751-9415","authenticated-orcid":false,"given":"Evelyn M.","family":"Horn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8410-4429","authenticated-orcid":false,"given":"Hilary M.","family":"DuBrock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reena","family":"Mehra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam S.","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna R.","family":"Hemnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane A.","family":"Leopold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8057-4244","authenticated-orcid":false,"given":"Milena K.","family":"Radeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas S.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serpil C.","family":"Erzurum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika B.","family":"Rosenzweig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Frantz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz P.","family":"Rischard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald J.","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Hassoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3188-7209","authenticated-orcid":false,"given":"Stephen C.","family":"Mathai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.chest.2024.02.009_bib1","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01913-2018","article-title":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension","volume":"53","author":"Simonneau","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.chest.2024.02.009_bib2","series-title":"Measuring Healthy Days","year":"2000"},{"issue":"1","key":"10.1016\/j.chest.2024.02.009_bib3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1513\/AnnalsATS.201412-572OC","article-title":"Health-related quality of life and survival in pulmonary arterial hypertension","volume":"13","author":"Mathai","year":"2016","journal-title":"Ann Am Thorac Soc"},{"issue":"2","key":"10.1016\/j.chest.2024.02.009_bib4","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00414-2020","article-title":"EmPHasis-10 as a measure of health-related quality of life in pulmonary arterial hypertension: data from PHAR","volume":"57","author":"Borgese","year":"2021","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.chest.2024.02.009_bib5","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1183\/09031936.06.00130405","article-title":"Measurement of quality of life in pulmonary hypertension and its significance","volume":"28","author":"Cenedese","year":"2006","journal-title":"Eur Respir J"},{"issue":"138","key":"10.1016\/j.chest.2024.02.009_bib6","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1183\/16000617.0063-2015","article-title":"Pulmonary arterial hypertension: the burden of disease and impact on quality of life","volume":"24","author":"Delcroix","year":"2015","journal-title":"Eur Respir Rev"},{"issue":"1","key":"10.1016\/j.chest.2024.02.009_bib7","first-page":"51","article-title":"Symptoms, impacts, and suitability of the Pulmonary Arterial Hypertension\u2013Symptoms and Impact (PAH-SYMPACTTM) questionnaire in patients with chronic thromboembolic pulmonary hypertension (CTEPH): a qualitative interview study","volume":"5","author":"Currie","year":"2021","journal-title":"JPRO"},{"issue":"5","key":"10.1016\/j.chest.2024.02.009_bib8","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.chest.2022.08.2206","article-title":"Considerations when selecting patient-reported outcome measures for assessment of health-related quality of life in patients with pulmonary hypertension: a narrative review","volume":"162","author":"Yarlas","year":"2022","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.chest.2024.02.009_bib9","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1378\/chest.12-2443","article-title":"Patient-reported outcomes assessed by the CAMPHOR questionnaire predict clinical deterioration in idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension","volume":"144","author":"McCabe","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.chest.2024.02.009_bib10","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12955-014-0130-3","article-title":"Quality of life as a prognostic marker in pulmonary arterial hypertension","volume":"12","author":"Fernandes","year":"2014","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.chest.2024.02.009_bib11","doi-asserted-by":"crossref","first-page":"00617","DOI":"10.1183\/23120541.00617-2020","article-title":"Health-related quality of life and disease progression in PAH patients: a 3-year study","volume":"7","author":"Halimi","year":"2021","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.chest.2024.02.009_bib12","first-page":"186","article-title":"The longitudinal use of EmPHasis-10 and CAMPHOR questionnaire health-related quality of life scores in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension","author":"Hendriks","year":"2021","journal-title":"Respir Med"},{"issue":"23","key":"10.1016\/j.chest.2024.02.009_bib13","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1161\/CIRCULATIONAHA.107.742510","article-title":"Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2","volume":"117","author":"Gali\u00e8","year":"2008","journal-title":"Circulation"},{"issue":"9630","key":"10.1016\/j.chest.2024.02.009_bib14","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(08)60919-8","article-title":"Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial","volume":"371","author":"Gali\u00e8","year":"2008","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.chest.2024.02.009_bib15","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1136\/ard.2007.069609","article-title":"Selective endothelin A receptor antagonism with sitaxsentan for pulmonary arterial hypertension associated with connective tissue disease","volume":"66","author":"Girgis","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.chest.2024.02.009_bib16","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.chest.2016.08.1473","article-title":"Macitentan improves health-related quality of life for patients with pulmonary arterial hypertension: results from the randomized controlled SERAPHIN trial","volume":"151","author":"Mehta","year":"2017","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.chest.2024.02.009_bib17","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJM199602013340504","article-title":"A\u00a0comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension","volume":"334","author":"Barst","year":"1996","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.chest.2024.02.009_bib18","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa020204","article-title":"Inhaled iloprost for severe pulmonary hypertension","volume":"347","author":"Olschewski","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.chest.2024.02.009_bib19","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1164\/ajrccm.165.6.2106079","article-title":"Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial","volume":"165","author":"Simonneau","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.chest.2024.02.009_bib20","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.jacc.2003.10.056","article-title":"Clinical efficacy of sildenafil in primary pulmonary hypertension: a randomized, placebo-controlled, double-blind, crossover study","volume":"43","author":"Sastry","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.chest.2024.02.009_bib21","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1378\/chest.07-0592","article-title":"Sildenafil improves health-related quality of life in patients with pulmonary arterial hypertension","volume":"133","author":"Pepke-Zaba","year":"2008","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.chest.2024.02.009_bib22","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1185\/03007990903210066","article-title":"Tadalafil therapy and health-related quality of life in pulmonary arterial hypertension","volume":"25","author":"Pepke-Zaba","year":"2009","journal-title":"Curr Med Res Opin"},{"issue":"4","key":"10.1016\/j.chest.2024.02.009_bib23","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1056\/NEJMoa1209655","article-title":"Riociguat for the treatment of pulmonary arterial hypertension","volume":"369","author":"Ghofrani","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.chest.2024.02.009_bib24","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1161\/CIRCRESAHA.117.311737","article-title":"PVDOMICS: a multi-center study to improve understanding of pulmonary vascular disease through phenomics","volume":"121","author":"Hemnes","year":"2017","journal-title":"Circ Res"},{"issue":"suppl 25","key":"10.1016\/j.chest.2024.02.009_bib25","doi-asserted-by":"crossref","first-page":"D42","DOI":"10.1016\/j.jacc.2013.10.032","article-title":"Definitions and diagnosis of pulmonary hypertension","volume":"62","author":"Hoeper","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.chest.2024.02.009_bib26","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jacc.2022.05.038","article-title":"Clinical characteristics and transplant-free survival across the spectrum of pulmonary vascular disease","volume":"80","author":"Hemnes","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.chest.2024.02.009_bib27","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1183\/09031936.00127113","article-title":"emPHasis-10: development of a health-related quality of life measure in pulmonary hypertension","volume":"43","author":"Yorke","year":"2014","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.chest.2024.02.009_bib28","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item Short-Form Health Survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Medical Care"},{"issue":"4","key":"10.1016\/j.chest.2024.02.009_bib29","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/0002-8703(92)90986-6","article-title":"Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Pimobendan Multicenter Research Group","volume":"124","author":"Rector","year":"1992","journal-title":"Am Heart J"},{"issue":"1","key":"10.1016\/j.chest.2024.02.009_bib30","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1465-9921-6-92","article-title":"Health-related quality of life in patients with pulmonary arterial hypertension","volume":"6","author":"Taichman","year":"2005","journal-title":"Respir Res"},{"issue":"5","key":"10.1016\/j.chest.2024.02.009_bib31","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.arbres.2012.12.007","article-title":"Health-related quality of life in a national cohort of patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension","volume":"49","author":"Roman","year":"2013","journal-title":"Arch Bronconeumol"},{"issue":"2","key":"10.1016\/j.chest.2024.02.009_bib32","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00124-2020","article-title":"EmPHasis-10 health-related quality of life score predicts outcomes in patients with idiopathic and connective tissue disease-associated pulmonary arterial hypertension: results from a UK multi-centre study","volume":"57","author":"Lewis","year":"2020","journal-title":"Eur Respir J"},{"issue":"10","key":"10.1016\/j.chest.2024.02.009_bib33","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.rmed.2008.04.016","article-title":"Evaluation of disease-specific health-related quality of life in patients with pulmonary arterial hypertension","volume":"102","author":"Zlupko","year":"2008","journal-title":"Respir Med"},{"key":"10.1016\/j.chest.2024.02.009_bib34","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/3924517","article-title":"Health-related quality of life in pulmonary hypertension and its clinical correlates: a cross-sectional study","volume":"2018","author":"Reis","year":"2018","journal-title":"Biomed Res Int"},{"issue":"17","key":"10.1016\/j.chest.2024.02.009_bib35","article-title":"EmPHasis-10 health-related quality of life and exercise capacity in chronic thromboembolic pulmonary hypertension after balloon angioplasty","volume":"11","author":"Sakamoto","year":"2022","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"9","key":"10.1016\/j.chest.2024.02.009_bib36","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.healun.2017.02.016","article-title":"The Giessen Pulmonary Hypertension Registry: survival in pulmonary hypertension subgroups","volume":"36","author":"Gall","year":"2017","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"4","key":"10.1016\/j.chest.2024.02.009_bib37","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1183\/09031936.00078411","article-title":"ASPIRE registry: assessing the Spectrum of Pulmonary hypertension Identified at a REferral centre","volume":"39","author":"Hurdman","year":"2012","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.chest.2024.02.009_bib38","doi-asserted-by":"crossref","DOI":"10.1177\/2045894018775056","article-title":"Pulmonary hypertension in chronic lung diseases: comparison to other pulmonary hypertension groups","volume":"8","author":"Chebib","year":"2018","journal-title":"Pulm Circ"},{"issue":"1","key":"10.1016\/j.chest.2024.02.009_bib39","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11136-005-3513-4","article-title":"The Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR): a Measure of Health-Related Quality of Life and Quality of Life for Patients with Pulmonary Hypertension","volume":"15","author":"McKenna","year":"2006","journal-title":"Qual Life Res"},{"issue":"1","key":"10.1016\/j.chest.2024.02.009_bib40","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12931-016-0388-6","article-title":"Development of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT\u00ae) questionnaire: a new patient-reported outcome instrument for PAH","volume":"17","author":"McCollister","year":"2016","journal-title":"Respir Res"},{"issue":"4","key":"10.1016\/j.chest.2024.02.009_bib41","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.chest.2018.04.027","article-title":"Psychometric Validation of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT) questionnaire: results of the SYMPHONY trial","volume":"154","author":"Chin","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.chest.2024.02.009_bib42","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/1477-7525-11-161","article-title":"Development and validation of the living with pulmonary hypertension questionnaire in pulmonary arterial hypertension patients","volume":"11","author":"Bonner","year":"2013","journal-title":"Health Qual Life Outcomes"},{"issue":"1","key":"10.1016\/j.chest.2024.02.009_bib43","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.healun.2007.10.004","article-title":"United States Validation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR)","volume":"27","author":"Gomberg-Maitland","year":"2008","journal-title":"J\u00a0Heart Lung Transplantation"}],"container-title":["CHEST"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369224001557?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369224001557?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T23:33:57Z","timestamp":1717803237000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369224001557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S0012369224001557"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2024.02.009","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Health-Related Quality of Life Across the Spectrum of Pulmonary Hypertension","name":"articletitle","label":"Article Title"},{"value":"CHEST","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2024.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American College of Chest Physicians. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}